Back

The effect of CYP2C19 gene polymorphism and clopidogrel dose on clinical outcomes in Asian populations with CAD receiving antiplatelet therapy.

28 August 2017 (09:15 - 09:24)
Organised by:
Congress Presentation Part of: Antithrombotic strategies in coronary artery disease Thrombosis and coagulation ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Wei Liu

Beijing Jishuitan Hospital, Beijing (China)

9 More presentations in this session

Presentation thumbnail
Antithrombotic treatment in patients with stable CAD and AF - 5-year follow-up data from the CLARIFY registry
Doctor R. Wakili (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Application of DAPT score to predict ischaemic and bleeding events in patients who underwent drug-eluting stent implantation: a landmark analysis of large pooled cohort
Doctor Y. Yoshikawa (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.
Doctor M. Bonaca (Aurora, US)
Abstract Slides Video
Presentation thumbnail
In-hospital switch of P2Y12 drugs in patients presenting with acute coronary syndrome: a meta-analysis of 14 observational and randomized studies including 10961 patients.
Doctor M. Bianco (Orbassano, IT)
Abstract Slides Video
Presentation thumbnail
Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: OLTAT registry
Doctor Q. Fischer (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Antithrombotic strategies in coronary artery disease

The Event

Event poster

ESC Congress 2017

28 August 2017 09:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources